Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4250694
Max Phase: Preclinical
Molecular Formula: C51H97N17O10
Molecular Weight: 1108.45
Molecule Type: Small molecule
Associated Items:
ID: ALA4250694
Max Phase: Preclinical
Molecular Formula: C51H97N17O10
Molecular Weight: 1108.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)C(C)C
Standard InChI: InChI=1S/C51H97N17O10/c1-27(2)22-36(61-32(11)69)45(74)65-38(24-29(5)6)47(76)67-39(25-30(7)8)48(77)66-37(23-28(3)4)46(75)63-35(18-15-21-59-51(56)57)44(73)68-41(31(9)10)49(78)64-34(16-12-13-19-52)43(72)62-33(17-14-20-58-50(54)55)42(71)60-26-40(53)70/h27-31,33-39,41H,12-26,52H2,1-11H3,(H2,53,70)(H,60,71)(H,61,69)(H,62,72)(H,63,75)(H,64,78)(H,65,74)(H,66,77)(H,67,76)(H,68,73)(H4,54,55,58)(H4,56,57,59)/t33-,34-,35-,36-,37-,38-,39-,41-/m0/s1
Standard InChI Key: UXHRTTKURFWXBR-YEFFYANISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1108.45 | Molecular Weight (Monoisotopic): 1107.7604 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines., 61 (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144] |
Source(1):